COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo

Identification of novel anti-cancer compounds with high efficacy and low toxicity is critical in drug development. High-throughput screening and other such strategies are generally resource-intensive. Therefore, in silico computer-aided drug design has gained rapid acceptance and popularity. We empl...

Descripción completa

Detalles Bibliográficos
Autores principales: Salim, Kowthar Y., Vareki, Saman Maleki, Danter, Wayne R., Koropatnick, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173065/
https://www.ncbi.nlm.nih.gov/pubmed/27150056
http://dx.doi.org/10.18632/oncotarget.9133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173065/
https://www.ncbi.nlm.nih.gov/pubmed/27150056
http://dx.doi.org/10.18632/oncotarget.9133

Ejemplares similares